Hsuan-Chieh Liao

Later Onset Fabry Disease, Cardiac Damage Progress in Silence

Ting‐Rong Hsu, Sheng‐Che Hung, Fu‐Pang Chang et al. · Journal of the American College of Cardiology · 2016 · 104 citations

Heart Failure, Structural Heart Disease, Cardiovascular Disease +6

Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan

Chih‐Kuang Chuang, Hsiang‐Yu Lin, Tuan‐Jen Wang et al. · Orphanet Journal of Rare Diseases · 2018 · 76 citations · Full text

Taiwan National Newborn Screening Program by Tandem Mass Spectrometry for Mucopolysaccharidoses Types I, II, and VI

Min-Ju Chan, Hsuan-Chieh Liao, Michael H. Gelb et al. · The Journal of Pediatrics · 2018 · 57 citations · Full text

Molecular Diagnostic Techniques, Engineering, Medicine +10

Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese hotspot mutation (IVS4+919G>A)

Haochuan Liu, Hsiang-Yu Lin, Chia‐Feng Yang et al. · Orphanet Journal of Rare Diseases · 2014 · 38 citations · Full text

Mass Spectrometry but Not Fluorimetry Distinguishes Affected and Pseudodeficiency Patients in Newborn Screening for Pompe Disease

Hsuan-Chieh Liao, Min-Ju Chan, Chia‐Feng Yang et al. · Clinical Chemistry · 2017 · 32 citations · Full text